Full video transcriptClick to expand
Auto-generated transcript of @theprescribeddose's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00I'm sorry.
- 0:02What language are you talking in now? It appears to be bollocks.
Do expired GLP-1 pens really lose potency? Here's the data
Quick answer
GLP-1 receptor agonists including semaglutide and tirzepatide are peptide-based injectables with manufacturer-defined stability windows that reflect real potency degradation data, not arbitrary labeling. Opened pens have shorter use-by periods than unopened ones, and storage conditions outside recommended temperature ranges can accelerate degradation independently of the printed expiry date. Patients experiencing unexpected loss of glycemic control or appetite suppression should consider medication integrity as a variable worth discussing with their prescriber.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Do expired GLP-1 pens really lose potency? Here's the data, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.
PubMed
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance
Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.
PubMed
Tirzepatide Once Weekly for the Treatment of Obesity
Primary SURMOUNT-1 trial source for tirzepatide weight-loss ranges and tolerability.
PubMed
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction
Used for continuation, stopping, and maintenance questions after initial weight loss.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
Do expired GLP-1 pens really lose potency? Here's the data should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Do expired GLP-1 pens really lose potency? Here's the data" from The prescribed dose 💊. We read the clip as a GLP-1 social video fact-checks claim about GLP-1 social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: GLP-1 receptor agonists including semaglutide and tirzepatide are peptide-based injectables with manufacturer-defined stability windows that reflect real potency degradation data, not arbitrary labeling.
The reason this review is not generic is the source wording and the canonical claim label "glp1 replying to adam brown922 would you use any other medication." In this clip, the useful excerpt is: "I'm sorry." That wording changes the review because it points to GLP-1 social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. GLP-1 social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
GLP-1 receptor agonists including semaglutide and tirzepatide are peptide-based injectables with manufacturer-defined stability windows that reflect real potency degradation data, not arbitrary labeling.
FormBlends verdict
GLP-1 social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- GLP-1 receptor agonists including semaglutide and tirzepatide are peptide-based injectables with manufacturer-defined stability windows that reflect real potency degradation data, not arbitrary labeling. Opened pens have shorter use-by periods than unopened ones, and storage conditions outside recommended temperature ranges can accelerate degradation independently of the printed expiry date. Patients experiencing unexpected loss of glycemic control or appetite suppression should consider medication integrity as a variable worth discussing with their prescriber.
- Semaglutide and tirzepatide are peptides: their molecular structure makes them more vulnerable to degradation than small-molecule drugs, and potency loss is real, not theoretical.
- Novo Nordisk prescribing data specifies opened semaglutide pens must be discarded after 56 days regardless of remaining volume, and unused pens should not be used past the printed expiry date.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Semaglutide and tirzepatide are peptides: their molecular structure makes them more vulnerable to degradation than small-molecule drugs, and potency loss is real, not theoretical.
- Novo Nordisk prescribing data specifies opened semaglutide pens must be discarded after 56 days regardless of remaining volume, and unused pens should not be used past the printed expiry date.
- A 2021 Manning et al. review in the Journal of Pharmaceutical Sciences confirmed that hydrolysis and oxidation are the primary degradation pathways for peptide injectables stored in solution.
- Temperature excursions matter as much as the expiry date: a 2019 Vitaliti et al. study found that brief heat exposure accelerated peptide degradation significantly, meaning an improperly stored pen may be compromised before its expiry date arrives.
- Degraded GLP-1 medication looks identical to intact medication. There is no visible, taste, or smell signal that potency has been lost, making it impossible for a patient to self-assess pen integrity.
- If medication cost or supply shortage is driving someone to consider using expired pens, this is a clinical conversation to have with a prescriber or pharmacist, not a risk to manage independently.
- Stability profiles differ across GLP-1 medications. Liraglutide, semaglutide, and tirzepatide have different formulations, and expiry guidance should not be assumed identical across all three.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @theprescribeddose actually say?
The creator's on-camera response to a question about using GLP-1 medications past their expiry date was, bluntly: "I'm sorry. What language are you talking in now? It appears to be bollocks." That's essentially a dismissal of the idea that expired GLP-1 pens are safe or effective to use. The caption does the heavier lifting here, arguing that GLP-1 medications are peptides that degrade over time, and that repeated needle piercing of the rubber stopper introduces contamination risk. The verbal clip is short on specifics, but the overall message is clear: don't use expired GLP-1 medications.
It's worth separating what was actually said on camera from what appears in the caption. The spoken transcript gives us almost nothing to fact-check scientifically. The caption, though, makes real pharmacological claims. We'll treat both together.
Does the science back this up?
Yes, mostly. Peptide-based drugs like semaglutide and tirzepatide are chemically less stable than small-molecule drugs, and degradation over time is a real phenomenon, not a pharmaceutical industry scare tactic.
Peptide degradation happens through several mechanisms: hydrolysis, oxidation, and physical aggregation. A 2021 review by Manning et al. in the Journal of Pharmaceutical Sciences confirmed that peptide formulations are particularly vulnerable to these pathways, especially once a pen device has been opened and exposed to temperature fluctuations. Novo Nordisk's own prescribing information for semaglutide specifies that opened pens should be discarded after 56 days, even if refrigerated, and unused pens should not be used past the printed expiry date. That guidance exists because the company conducted stability testing showing measurable potency decline beyond those windows.
The contamination point in the caption is also legitimate. Every time a needle is attached and the rubber septum is pierced, there is a theoretical pathway for microbial ingress. This is why single-use cartridge designs exist in the first place.
What did they get wrong (or right)?
The creator got the general direction right: expired GLP-1 pens are a bad idea. But the delivery, a one-liner dismissal with almost no explanation, doesn't actually educate anyone. Saying something is "bollocks" doesn't tell a patient why, or how expired medication could affect their treatment.
The caption's claim that peptides "break down over time" is accurate but incomplete. The rate of degradation matters enormously. A pen that expired two weeks ago stored in a refrigerator is a very different situation from one that sat in a car during summer for three months. Blanket "throw it out" messaging ignores this nuance and may contribute to unnecessary medication waste, which is a real problem given the cost and supply issues around GLP-1 drugs.
There's also no acknowledgment that stability data varies by specific medication. Liraglutide, semaglutide, and tirzepatide have different formulations and different stability profiles. Treating them as interchangeable on this point is an oversimplification.
What should you actually know?
Expiry dates on GLP-1 pens are based on real stability testing, not arbitrary bureaucracy. The peptide backbone in these medications can degrade in ways that are invisible to the user: the liquid looks the same, smells the same, and the pen still clicks. You would not know the medication has lost potency until you notice your blood glucose or appetite control is worse than expected.
Storage conditions matter as much as the date on the label. A 2019 study by Vitaliti et al. in Drug Design, Development and Therapy found that temperature excursions, even brief ones, accelerated peptide degradation in injectable formulations significantly. If your pen was left unrefrigerated for more than the manufacturer-specified window, the expiry date printed on the label is no longer meaningful because the clock started running faster the moment it got warm.
If cost or supply is driving someone to consider using an expired pen, that's a conversation to have with a prescriber or pharmacist, not a workaround to manage alone.
The bottom line
The creator's instinct is correct: don't use expired GLP-1 pens. But the reasoning offered, a dismissive one-liner plus a caption, is thin. Patients deserve a better explanation than "it appears to be bollocks." Peptide stability is genuinely complex, and the actual risks depend on storage history, specific medication, and how far past expiry the pen is. The science supports caution. It doesn't support panic, and it doesn't support using expired medication either.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
The prescribed dose 💊 · TikTok creator
5.9K views on this video
Replying to @Adam Brown922 would you use any other medication past its expiry date? Your GLP-1 isn’t a fine wine 🍷 — it won’t get better with age. GLP-1 pens have an expiry date for a reason 👀 ❌ They’re peptides – and peptides break down over time (bye-bye potency). ❌ Every time you pierce that rubber bung, tiny microbes can sneak in 🦠 (hello infection risk). ❌ Heat, cold, and random temperature changes mess with the medicine 🥶🥵. ❌ And safety studies only cover the time on the label – aft
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about semaglutide?
Semaglutide and tirzepatide are peptides: their molecular structure makes them more vulnerable to degradation than small-molecule drugs, and potency loss is real, not theoretical.
What does the video say about novo nordisk prescribing data specifies opened semaglutide pens must be?
Novo Nordisk prescribing data specifies opened semaglutide pens must be discarded after 56 days regardless of remaining volume, and unused pens should not be used past the printed expiry date.
What does the video say about a 2021 manning et al. review in the journal of?
A 2021 Manning et al. review in the Journal of Pharmaceutical Sciences confirmed that hydrolysis and oxidation are the primary degradation pathways for peptide injectables stored in solution.
What does the video say about temperature excursions matter as much as the expiry date: a?
Temperature excursions matter as much as the expiry date: a 2019 Vitaliti et al. study found that brief heat exposure accelerated peptide degradation significantly, meaning an improperly stored pen may be compromised before its expiry date arrives.
What does the video say about degraded glp-1 medication looks identical to intact medication. there?
Degraded GLP-1 medication looks identical to intact medication. There is no visible, taste, or smell signal that potency has been lost, making it impossible for a patient to self-assess pen integrity.
What does the video say about if medication cost?
If medication cost or supply shortage is driving someone to consider using expired pens, this is a clinical conversation to have with a prescriber or pharmacist, not a risk to manage independently.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by The prescribed dose 💊, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.